QEI
MEDP icon

QSV Equity Investors’s Medpace MEDP Stock Holding History

QSV Equity Investors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,641
Closed -$1.72M – 93
2025
Q1 		$1.72M Sell
5,641
-14
-0.2% -$4.71K 1.78% 17
2024
Q4 		$1.88M Buy
5,655
+6
+0.1% +$2.04K 1.81% 17
2024
Q3 		$1.89M Sell
5,649
-249
-4% -$94.6K 1.77% 17
2024
Q2 		$2.43M Sell
5,898
-159
-3% -$63K 2.54% 2
2024
Q1 		$2.45M Sell
6,057
-1,261
-17% -$443K 2.36% 1
2023
Q4 		$2.24M Buy
+7,318
New +$1.98M 2.18% 2

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

QSV Equity Investors's MEDP Position: Q2 2025 in Review

QSV Equity Investors sold out of Medpace (MEDP) in Q2 2025, closing a stake of 5,641 shares — an estimated $1.72M sold.

QSV Equity Investors first reported a position in MEDP in Q4 2023 and held it in 6 quarters. The position peaked at $2.45M in Q1 2024. 602 funds tracked by Wall St. Rank hold MEDP as of Q2 2025.

  • QSV Equity Investors reported no remaining Medpace position as of Q2 2025 after selling out during the quarter.
  • QSV Equity Investors sold 5,641 Medpace shares in Q2 2025, an estimated $1.72M.
  • QSV Equity Investors first reported a position in Medpace in Q4 2023 and held it in 6 quarters.
  • QSV Equity Investors's Medpace position peaked at $2.45M in Q1 2024.
  • 602 funds tracked by Wall St. Rank held Medpace as of Q2 2025.

Based on QSV Equity Investors's 13F filing for Q2 2025, filed 13 Aug 2025.